These observations may be attributable to the ever increasing degree of immobility and fatigue observed among MS patients, prolonged steroid and DMD usage (68% in our study), and increasing life expectance predisposing MS patients to comorbid illnesses. This evidence concerns the gene DMD and myeloid sarcoma.